1 / 40

Diagnosis and Management of Malignant Pleural Effusion

Diagnosis and Management of Malignant Pleural Effusion. 衛生署桃園醫院內科加護病房主任 莊子儀醫師 2006 年 7 月 20 日. Etiology of Malignant Effusion. Lung cancer: 37.5%, especially adenocarcinoma Breast cancer: 16.8% Lymphoma: 11.5%, most common in young adult. Etiology of Malignant Effusion.

lexine
Télécharger la présentation

Diagnosis and Management of Malignant Pleural Effusion

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Diagnosis and Management of Malignant Pleural Effusion 衛生署桃園醫院內科加護病房主任 莊子儀醫師 2006年7月20日

  2. Etiology of Malignant Effusion • Lung cancer: 37.5%, especially adenocarcinoma • Breast cancer: 16.8% • Lymphoma: 11.5%, most common in young adult

  3. Etiology of Malignant Effusion • Increasing production of effusion: • Increasing vascular permeability: invasion of pleural vessels by tumor, cytokines, injury, infection etc. • Increasing vascular hydrostatic gradient: decreased pleural pressure by atelectasis, increased venous pressure by SVC syndrome, decreased plasma osmotic pressure by hypoalbuminemia • Nonvascular entry by thoracic duct: chylothorax

  4. Etiology of Malignant Effusion • Decreasing exit of effusion: • Increasing resistance to lymphatic flow: infiltration of parietal pleura or mediastinal lymph nodes by tumor seeding • Increasing gradient opposing lymphatic flow: decreased pleural pressure by atelectasis, increased venous pressure by SVC syndrome

  5. Clinical Presentation • Dyspnea • Cough • Chest pain

  6. Radiographic Evaluation • Chest X-ray

  7. Chest X-ray • Amount of pleural effusion • More than 2/3 hemithorax or even entire hemithorax • 55% of large and massive effusions • Other causes: empyema and TB effusions • Cytology diagnosis of large and small effusions: no significant difference (63% vs. 53%)

  8. Chest X-ray • Mediastinum position • Shift away from a large effusion • Midline mediastinum in large effusion: significant lung collapse, fixed mediastinum LAP • Shift toward a large effsuion: trapped lung due to main-stem bronchial obstruction

  9. Radiographic Evaluation • Chest X-ray • Chest CT

  10. Chest CT • Pleural surfaces, lung parenchyma, chest wall and mediastinum • Malignant pleural disease: pleural thickening (>1 cm), irregularity, nodules • Pleural thickening: also seen in empyema • Pleural nodules: only 17% in malignant effusions • Other features: lung mass, chest wall involvement, mediastinal LAP, hepatic metastases

  11. Radiographic Evaluation • Chest X-ray • Chest CT • Chest echo

  12. Chest Echo • Pleural surfaces, lung parenchyma, chest wall and pleural effusion • Pleural effusion: echo-free • Pleural thickening and nodules • Echo-guide thoracocentesis • Echo-guide pleural biopsy

  13. Diagnosis • Pleural effusion • Cytology • Pathology

  14. Pleural effusion • Grossly bloody: most common cause of bloody effusion • Serosanguineous effusion • Cell differentiation: lymphocytes predominant • Eosinophilia: can not exclude malignant effusion

  15. Pleural effusion • Almost always exudate • Lactate dehydrogenase (LDH): increased cell turnover and lysis • Low glucose concentration and low pH level: possible shorter survival • pH < 7.20: easily failure of pleurodesis

  16. Cytology • Adenocarcinoma: most likely to be positive • Low pH: greater tumor burden • Cytology diagnosis of large and small effusions: no significant difference (63% vs. 53%) • Body fluid + cell block

  17. Pathology • Pleural biopsy • Closed needle biopsy • Cope needle • Abrams needle • Urocut needle

  18. Cope Needle

  19. Abrams Needle

  20. Urocut Needle

  21. Diagnostic Procedures • Diagnostic thoracocentesis under echo-guide • Send pleural effusion for routine, BCS (LDH, protein, glucose), Gram/AFB stain, cytology, B/C, plus ABG (for pH) • Pleural biopsy under echo-guide • Send pleura for pathology and TB tissue/C • Therapeutic thoracocentesis under echo-guide • Send pleural effusion for body fluid + cell block

  22. Primary Tumor (T) • T4: • A tumor of any size with invasion of the mediastinum, or involving heart, great vessels, trachea, esophagus, vertebral bodies, carina, • or with the presence of malignant pleural/pericardial effusion, • or exudative pleural effusion without evidence of obstructive pneumonitis, • or with satellite tumor within the lobe of primary tumor at chest CT

  23. Management • Symptom-oriented management • Less than 1/3 hemithorax, C/T sensitive tumor • C/T at first, F/U regularly • Slowly recurring effusion, short life span • Repeated therapeutic thoracocentesis • More than 2/3 hemithorax, no airway obstruction • Pigtail insertion for pleurodesis within 24 hours

  24. Management • Before pleurodesis • Daily drainage amount < 100-150 ml • Confirm with chest echo • Ability of lung re-expansion • Chemical pleurodesis • Mnocycline injection • Beta-iodine injection • OK-432 injection

  25. Management • Pre-medication • 2% xylocaine 10ml in 50ml normal saline • Minocycline injection • After 15 minutes, 300mg Minocycline in 50ml normal saline • Clamp catheter/tube, change position 2-6 hours • Unclamp catheter/tube, low pressure suction

  26. Management • Pre-medication • 2% xylocaine 10ml in 50ml normal saline • Beta-iodine injection • After 15 minutes, 10 ml beta-iodine in 40ml normal saline • Clamp catheter/tube, change position 2-6 hours • Unclamp catheter/tube, low pressure suction

  27. Management • Indwelling catheter • Good outpatient situation • Good for trapped lung • Pigtail catheter with drainage bag • Chest tube with Heimlich valve

  28. Management

  29. Complication • Re-expansion lung edema • Empyema • Restricted lung disease • Trapped lung

  30. Prognosis • Medium survival • Lung cancer with malignant effusion: 3 months • Breast cancer with malignant effusion: 5 months • Mesothelioma with malignant effusion: 6 months • Lymphoma with malignant effusion: 9 months

  31. Thank You for Attention • Reference: • Murray and Nadel’s Textbook of Respiratory Medicine, 4th edition, 2005 • Light and Lee’s Textbook of Pleural Disease, 1st edition, 2003 • Mathis and Lessnau’s Atlas of Chest Sonography, 1st edition, 2003

More Related